Zinbryta and Clexane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zinbryta (daclizumab) and Clexane (enoxaparin sodium). Common drug interactions include pneumonia among females and acute disseminated encephalomyelitis among males.

The phase IV clinical study analyzes what interactions people have when they take Zinbryta and Clexane. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Zinbryta?

Zinbryta has active ingredients of daclizumab. eHealthMe is studying from 2,382 Zinbryta users. Check the latest studies of Zinbryta.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

On Jul, 15, 2026

16 people who take Zinbryta and Clexane together, and have interactions are studied.

What are the common drug interactions of Zinbryta and Clexane, by gender? *:

female:

Pneumonia
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
Rash
Urinary tract infection
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Hypertension (high blood pressure)
Fall
Fibula fracture
Joint injury
Arthralgia (joint pain)

male:

Acute disseminated encephalomyelitis (acute intense attack of inflammation (swelling) in the brain and spinal cord)
Brain neoplasm (tumour of brain)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Alopecia areata (patchy baldness that typically begins with rapid hair loss)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Drug eruption (adverse drug reaction of the skin)
Eczema asteatotic (severe dry skin- during the winter months and in the elderly)

What are the common drug interactions of Zinbryta and Clexane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Encephalitis (inflammation of the brain)
Oral herpes (viral infection of mouth)
Pneumonia
Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
Rash
Urinary tract infection
Fall
Fibula fracture
Joint injury
Hypertension (high blood pressure)

40-49:

Drug eruption (adverse drug reaction of the skin)
Eczema asteatotic (severe dry skin- during the winter months and in the elderly)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Alopecia areata (patchy baldness that typically begins with rapid hair loss)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)

50-59:

Acute disseminated encephalomyelitis (acute intense attack of inflammation (swelling) in the brain and spinal cord)
Brain neoplasm (tumour of brain)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Pyogenic granuloma (small, raised, red bumps on the skin)

60+:

n/a

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 93.75%
Pain: 5 people, 31.25%
Salivary Hypersecretion (excess saliva secretion): 3 people, 18.75%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 18.75%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 3 people, 18.75%
Gait Disturbance: 3 people, 18.75%
High Blood Cholesterol: 2 people, 12.50%
Rickets (softening of bones): 2 people, 12.50%
Diabetes: 2 people, 12.50%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Zinbryta and Clexane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously